Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension

Author： Angeli Fabio   Verdecchia Paolo   Pascucci Chiara   Poltronieri Cristina   Reboldi Gianpaolo  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.3, 2013-03, pp. : 379-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

By Barrios Vivencio   Escobar Carlos  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2249-2261

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment

By Reboldi Gianpaolo   Gentile Giorgio   Angeli Fabio   Verdecchia Paolo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 115-128

Informa Healthcare

Access to resources Recommend Favorite

Azilsartan Medoxomil: A Review of its Use in Hypertension

By Perry Caroline M.  

Clinical Drug Investigation, Vol. 32, Iss. 9, 2012-09 ,pp. : 621-639

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment

By Chaumais Marie-Camille  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1193-1205

Informa Healthcare

Access to resources Recommend Favorite

Olmesartan medoxomil beneficial in hypertension

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite